Ausschlusskriterien
is a female patient who is pregnant or lactating
boolean
has any contraindication to the MRM examination (e.g. metal implants, phobia) or the use of gadolinium-containing contrast agents.
boolean
has received any contrast agent within 24 hours prior to the study MRM, or is scheduled to receive any contrast agent within 24 hours after the study MRM.
boolean
has severe cardiovascular disease (e.g., known long QT syndrome, acute myocardial infarction [< 14 days], unstable angina, congestive heart failure New York Heart Association class IV) or acute stroke (< 48 hours)).
boolean
has acute renal insufficiency of any severity due to hepato-renal syndrome or in the peri-operative liver transplantation period or who has acute or chronic moderate or severe renal insufficiency (glomerular filtration rate < 60 mL/min/1.73m2).
boolean
has received chemotherapy or hormonal therapy for breast cancer within 6 months.
boolean
has received hormone replacement therapy within 4 weeks prior to study drug administration.
boolean
is scheduled or likely to require a surgery and/or biopsy in the time period up to 24 hours following study drug application
boolean
has prior excisional biopsy or breast surgery < 6 months before enrollment and between XRM and study MRM
boolean